|

U.S. Stocks: AYX, BABA, BIDU, CAT, CBMG, CDNA, CDXS Technical Analysis [Video]

ALTERYX INC [AYX], ALIBABA GROUP [BABA], BAIDU INC [BIDU], CATERPILLAR INC [CAT], CELLULAR BIOMEDICINE GROUP [CBMG], CAREDX INC [CDNA], CODEXIS INC [CDXS] Price Technical Analysis Elliott Wave and Trading Levels  - tradinglounge

ALTERYX INC [AYX] (NYSE)
Alteryx is an American computer software company based in Irvine, California, with a development center in Broomfield, Colorado. The company's products are used for data science and analytics. The software is designed to make advanced analytics accessible to any data worker.

ALIBABA GROUP [BABA] (NYSE - ADR)
Alibaba Group Holding Limited, also known as Alibaba Group and as Alibaba.com, is a Chinese multinational technology company specializing in e-commerce, retail, Internet, and technology

BAIDU INC [BIDU] (NASDAQ - ADR)
Baidu, Inc. is a Chinese multinational technology company specializing in Internet-related services and products and artificial intelligence, headquartered in Beijing's Haidian District. It is one of the largest AI and internet companies in the world.

CATERPILLAR INC [CAT] (NYSE)
Caterpillar Inc. is an American Fortune 100 corporation which designs, develops, engineers, manufactures, markets, and sells machinery, engines, financial products, and insurance to customers via a worldwide dealer network. It is the world's largest construction equipment manufacturer.

CELLULAR BIOMEDICINE [CBMG] (NASDAQ)
Cellular Biomedicine Group, Inc. operates as a biopharmaceutical company. The Company develops cell therapies for the treatment of cancer and degenerative diseases. Cellular Biomedicine Group serves patients in China and the United States

CAREDX INC [CDNA] (NASDAQ)
CareDx CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.

CODEXIS [CDXS] (NASDAQ)
Codexis, Inc. is a leading protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food

Risk Disclaimer

As with any day trading or investing opportunity there is a risk of losing part or all of your capital that Trading Lounge expresses opinions on.

Note: Historical trading results are no guarantee of future returns.

Some investments are inherently more risky than others.  At worst, you could lose your entire investment and more, so seek financial advice from your financial adviser.

TradingLounge™ uses a range of technical analysis tools, such as Elliott Wave, software and basic fundamental analysis as well as economic forecasts aimed at minimising the potential for loss.  

The advice we provide through our TradingLounge™ websites and our TradingLounge™ Membership and social media platforms has been prepared without taking into account your particular objectives, financial situation or needs. Reliance on such advice, information or data is at your own risk.

The decision to trade and the method of trading is for you alone to decide, tradinglounge takes no responsibility whatsoever for your trading profits or losses.

This information is of a general nature only, so you should, before acting upon any of the information or advice provided by us, 
consider the appropriateness of the advice in light of your own objectives, financial situation or needs. 
Therefore, you should consult your financial advisor or accountant to determine whether trading in Indices ETFs Stocks shares Forex  CFDs Options Spread Betting
derivatives of any kind / products are appropriate for you in light of your financial trading circumstances.

Author

Peter Mathers

Peter Mathers

TradingLounge

Peter Mathers started actively trading in 1982. He began his career at Hoei and Shoin, a Japanese futures trading company.

More from Peter Mathers
Share:

Editor's Picks

EUR/USD consolidates around 1.0900, bullish bias remains ahead of key US data

The EUR/USD pair is seen consolidating its strong gains registered over the past two days and oscillating in a narrow band during the Asian session on Tuesday. Spot prices currently trade around the 1.1900 mark, just below an over one-week high touched the previous day.

GBP/USD tilts bullish as markets barrel toward mid-week NFP print

GBP/USD is holding a broader bullish structure on the daily chart, with price trading well above the 50 Exponential Moving Average at 1.3507 and the 200 EMA at 1.3310, confirming the intermediate uptrend that has been in place since the November 2025 low near 1.2300. 

Gold retreats below $5,050 on profit-taking ahead of US data

Gold price attracts some sellers in the Asian session on Tuesday, falling back below $5.050. The precious metal edges lower amid improved risk sentiment and some profit-taking. Traders look to the US Retail Sales data and Fedspeak due later in the day ahead of Wednesday's Nonfarm Payrolls release.  

Litecoin eyes $50 as heavy losses weigh on investors

Following a strong downtrend across the crypto market over the past week, Litecoin holders are under immense pressure. The Bitcoin fork has trimmed about $1.81 billion from its market capitalization since the beginning of the year, sending it below the top 20 cryptos by market cap.

The market is buying everything again but is it dancing on a borrowed floor

The market has a short memory and a fast trigger finger. Last week’s liquidation barely cooled before risk came roaring back, pushing the S&P toward record territory and reinstalling Big Tech as the engine of choice. This is not discovery. It is re exposure.

Ripple exposed to volatility amid low retail interest, modest fund inflows

Ripple (XRP) is extending its intraday decline to around $1.40 at the time of writing on Monday amid growing pressure from the retail market and risk-off sentiment that continues to keep investors on the sidelines.